Doctor profile · Federal record
Dr. Edward Lewiecki, M.D.
Internal Medicine Physician (CMS: Internal Medicine) · Albuquerque, NM
- NPI 1861441735
- Accepts Medicare
- MIPS 61.5 / 100 · 2023
- 54 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
300 Oak St Ne
Albuquerque, NM 871064725
(505) 855-5525
fax (505) 884-4006
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- January 31, 2008
- Year of graduation
- 1972 — 54 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- New Mexico #73-160
- Medicaid (2)
- NM #000-16667 · NM #000Z5691
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861441735. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
139,590
Distinct HCPCS
10
Medicare allowed
$2,334,645
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 79,965 | 72 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 54,480 | 574 | $23 | |
96372 |
Injection of drug or substance under skin or into muscle | 1,292 | 633 | $13 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 775 | 775 | $35 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 748 | 713 | $122 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 616 | 546 | $86 | |
77089 |
Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 462 | 462 | $37 | |
J3489 |
Injection, zoledronic acid, 1 mg | 420 | 83 | $9 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 356 | 124 | $53 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 159 | 159 | $211 |
In context: peer comparison
Among 97 peers in this city , average services per provider: 383. This provider delivers 364× the peer median.Open Payments
Industry payments received
All-time total
$99,336
Transactions
163
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Kyowa Kirin, Inc. | 72 | $40,565.09 | |
| Amgen Inc. | 30 | $32,544.15 | |
| Radius Health, Inc. | 47 | $23,510.54 | |
| UCB SA | 1 | $1,925.00 | |
| Alexion Pharmaceuticals, Inc. | 9 | $447.40 | |
| Organon Llc | 1 | $228.00 | |
| Ultragenyx Pharmaceutical Inc. | 2 | $76.41 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $39.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
420
Patients
83
Total drug cost
$432,537
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Alendronate Sodium | Generic | 201 | 67 | $3,036 |
| Tymlos (Abaloparatide) | Brand | 103 | 16 | $270,047 |
| Forteo (Teriparatide) | Brand | 24 | 0 | $109,455 |
| Risedronate Sodium | Generic | 15 | 0 | $1,273 |
| Cinacalcet Hcl | Generic | 14 | 0 | $13,353 |
| Evenity (2 Syringes) (Romosozumab-Aqqg) | Brand | 14 | 0 | $34,223 |
| Celecoxib | Generic | 13 | 0 | $564 |
| Levothyroxine Sodium | Generic | 13 | 0 | $307 |
| Sertraline Hcl | Generic | 12 | 0 | $87 |
| Ultra-Fine Micro Pen Needle (Pen Needle, Diabetic) | Brand | 11 | 0 | $191 |
Hospital affiliations
Frequently asked questions
What is Dr. Edward Lewiecki's medical specialty?
Dr. Edward Lewiecki practices Internal Medicine Physician in Albuquerque, NM.
Where does Dr. Edward Lewiecki practice?
Dr. Edward Lewiecki practices at 300 Oak St Ne, Albuquerque, NM 871064725. Office phone: 5058555525.
What is Dr. Edward Lewiecki's NPI?
Dr. Edward Lewiecki's National Provider Identifier (NPI) is 1861441735, issued by NPPES.
Does Dr. Edward Lewiecki accept Medicare assignment?
Yes. Dr. Edward Lewiecki accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Edward Lewiecki commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.